Daragon A, Mejjad O, Czernichow P, Louvel J P, Vittecoq O, Durr A, Le Loët X
Department of Rheumatology, CHU de Rouen, France.
Ann Rheum Dis. 1995 May;54(5):375-8. doi: 10.1136/ard.54.5.375.
To compare glucose metabolism in patients with vertebral hyperostosis (VH), with that in control patients.
We studied 50 patients aged 60 years or more who had VH according to Resnick's criteria, and 50 control patients without VH, matched for sex, age, weight and height. Plasma glucose was evaluated before and 120 minutes after ingestion of 75 g glucose. World Health Organisation criteria for diabetes mellitus (DM) were used. Radiographs of the pelvis and thoracic and lumbar spine were performed and read blind by two physicians.
Statistical analysis showed no difference between cases and control patients for prevalence of DM, and plasma glucose at 0 and 120 minutes.
These data suggest that glucoregulation in patients with VH does not differ from that in matched controls.
比较椎体骨质增生(VH)患者与对照患者的葡萄糖代谢情况。
我们研究了50例60岁及以上符合雷斯尼克标准的VH患者,以及50例无VH的对照患者,这些对照患者在性别、年龄、体重和身高方面进行了匹配。在摄入75克葡萄糖之前和之后120分钟评估血浆葡萄糖。采用世界卫生组织糖尿病(DM)标准。拍摄骨盆以及胸椎和腰椎的X线片,并由两名医生进行盲法阅片。
统计分析显示,病例组和对照组在DM患病率以及0分钟和120分钟时的血浆葡萄糖方面无差异。
这些数据表明,VH患者的血糖调节与匹配的对照组没有差异。